Vesicoureteral Reflux Imaging: A National Analysis in Commercially Insured Children From 2012 to 2021
American Journal of Roentgenology · 2024
DOI: 10.2214/ajr.24.31206 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Roentgenology, 2024. Verfasst von Shireen E Hayatghaibi und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Cincinnati College of Medicine, Cincinnati, OH. Hauptthemen laut MEDLINE: Vesico-Ureteral Reflux. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: AHRQ HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
In this national commercial claims database analysis, the number of outpatient pediatric VUR imaging examinations decreased from 48,843 in 2012–2016 to 31,423 in 2017–2021. Imaging modalities’ distribution varied over time, with increased use of VCUG (> 90% of examinations in both periods), decreased use of nuclear cystography, and emergence of ceVUS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Cincinnati College of Medicine, Cincinnati, OH.
- Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
- Harvard Pilgrim Health Care Institute, Boston, MA.
- Harvard Medical School, Boston, MA.
Förderung
- AHRQ HHS
Zitieren
APA
Hayatghaibi, S. E., Wright, D. R., & Trout, A. T. (2024). Vesicoureteral Reflux Imaging: A National Analysis in Commercially Insured Children From 2012 to 2021. American Journal of Roentgenology. https://doi.org/10.2214/ajr.24.31206
Vancouver
Hayatghaibi SE, Wright DR, Trout AT. Vesicoureteral Reflux Imaging: A National Analysis in Commercially Insured Children From 2012 to 2021. American Journal of Roentgenology. 2024. doi:10.2214/ajr.24.31206
BibTeX
@article{Hayatghaibi2024,
author = {Hayatghaibi, Shireen E and Wright, Davene R and Trout, Andrew T},
title = {Vesicoureteral Reflux Imaging: A National Analysis in Commercially Insured Children From 2012 to 2021},
journal = {American Journal of Roentgenology},
year = {2024},
doi = {10.2214/ajr.24.31206}
}
EUVIMED